According to a Wall Street Journal report, UnitedHealth Group (UNH) is under investigation by the Department of Justice (DOJ) over alleged Medicare fraud. UnitedHealth's stock is under pressure in Thursday's trading session. Yahoo Finance senior health reporter Anjalee Khemlani lays out the timeline of events the health insurer has had to weather, including the sudden departure of CEO Andrew Witty this week, last year's cyberattack, and the killing of Brian Thompson — the chief executive of UnitedHealth's insurance business — in December 2024. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. Video Transcript 00:00 Speaker A Well, shares of UnitedHealth Group, they're sinking today, and that's after a report from the Wall Street Journal saying that the company is under criminal investigation for possible Medicare fraud. For more, we've got our Yahoo Finance senior health reporter, Anjali Khemlani. So Anjali, what's the story here? 00:17 Anjali Khemlani Yeah, well, on that note from the Wall Street Journal story, UnitedHealth Group has already denied that report, saying in the statement today that they have not been notified by the Department of Justice of the supposed criminal investigation reported in, they called the Wall Street Journal for without attribution in that story yesterday. And this is just the latest development in what has been a really rough past one and a half years for the healthcare giant. If you rewind all the way back to December 2023, it was riding high. The company was boasting having 10% of the country's physicians or almost 90,000 physicians as part of its Optum health business, and analysts were speculating about it becoming the first trillion-dollar healthcare company. But since then, almost like the Titanic hitting the iceberg, there's been one hit after another, and this company has really been taking on water. First, the cyber attack in February 2024, Change Healthcare subsidiary, it got massively attacked. The company initially underestimated the impact of that, and it just appeared to be on the path of recovery soon after that. Uh, and then they just suffered another setback, the tragic killing of insurance CEO Brian Thompson. And that really unleashed unprecedented backlash, making UnitedHealth basically the face of the frustrations against the health insurance industry from the general public. The company was actually recently sued by investors for allegedly concealing how much of an impact that has even had on the company. Then you pile onto that the company's first quarter earnings miss, uh, in large due to increased Medicare costs, and then there was the surprise CEO shake up earlier this week. So all of this put together begs the question, is this vertically integrated giant suffering a culmination of management failures or has this been a series of unfortunate events? And that's something that Wall Street is looking at. They seem to be losing faith in the stock. You saw on your screen, just down about 12%, it's been teetering between 12 and 13 all day. It's lost more than five years worth of gains in the past one month alone and is responsible for actually dragging down the Dow. Since November 2024, when UnitedHealth traded at an all-time high, its stock has declined and accounted for 80% of the Dow's decline since that date, which is down more than 2,500 points. It's also a heavily weighted stock in the S&P, contributing to the healthcare subsector, and that has become the worst performing subsector in the S&P year to date, down more than 5 and a half percent. It's why Jared Holz, Mr. Jared Holz, sent a note to clients today that this could kick UnitedHealth out of the Dow. And he said that there's some risk in the name being removed from the Dow at some point, especially because they lost market cap from 600 billion down to 300 billion in the last month. And until there's, you know, evidence of greater consistency, there's just a question of what this company is going to be doing. So how is this newly appointed legendary CEO, Stephen Hemsley, who was credited with building United into the behemoth that it is today, going to right-size this ship? That's something the street has to contend with, and we'll all be waiting to find out. But clearly, the street is sending a signal today that they are not happy with some of these changes and maybe aren't going to be waiting around to find out. 06:20 Speaker A All right. Thank you, Anj. Appreciate it. Related Videos 01:39 Meta delays release of flagship AI model, Behemoth: WSJ Yahoo Finance Video • 28 minutes ago 16:26 David Hunt on His PGIM Tenure, Private Credit, Liquidity Bloomberg • 1 hour ago 01:00 UnitedHealth's reported investigation, Cisco & Pinterest upgraded Yahoo Finance Video • 2 hours ago 04:19 Trading Platform EToro Makes Its Market Debut Bloomberg • 2 hours ago View Comments
UnitedHealth stock crushed: A timeline of the insurer's last year
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...